Skip Navigation
Skip to contents

CPP : Cardiovascular Prevention and Pharmacotherapy

Sumissioin : submit your manuscript
SEARCH
Search

Search

Page Path
HOME > Search
4 "Diet"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Article
Modifiable risk factors for coronary artery disease in the Indonesian population: a nested case-control study
Anggoro Budi Hartopo, Maria Patricia Inggriani, Brilliant Winona Jhundy, Jajah Fachiroh, Putri Tiara Rosha, Ratri Kusuma Wardani, Fatwa Sari Tetra Dewi
Cardiovasc Prev Pharmacother. 2023;5(1):24-34.   Published online January 31, 2023
DOI: https://doi.org/10.36011/cpp.2023.5.e3
  • 1,959 View
  • 85 Download
Abstract PDF
Background
There is a lack of data on modifiable coronary artery disease (CAD) risk factors in the Indonesian population, hindering the implementation of assessments and prevention programs in this population. This study investigated modifiable risk factors for CAD among Indonesians by comparing them between CAD-proven patients and healthy subjects from a similar population.
Methods
In this nested, matched case-control study, the cases were patients from a referral hospital in Yogyakarta, Indonesia and the controls were respondents in a population surveillance system in Yogyakarta, Indonesia. The cases were 421 patients who had undergone coronary angiography, showing significant CAD. The sex- and age-matched controls were 842 respondents from the Universitas Gadjah Mada Health and Health and Demographic Surveillance System Sleman who indicated no CAD presence on a questionnaire. The modifiable CAD risk factors compared between cases and controls were diabetes mellitus, hypertension, central obesity, smoking history, physical inactivity, and less fruit and vegetable intake. A multivariate regression model was applied to determine independent modifiable risk factors for CAD, expressed as adjusted odds ratios (AORs).
Results
A multivariate analysis model of 1,263 subjects including all modifiable risk factors indicated that diabetes mellitus (AOR, 3.32; 95% confidence interval [CI], 2.09–5.28), hypertension (AOR, 2.52; 95% CI, 1.76–3.60), former smoking (AOR, 4.18; 95% CI, 2.73–6.39), physical inactivity (AOR, 15.91; 95% CI, 10.13–24.99), and less fruit and vegetable intake (AOR, 5.42; 95% CI, 2.84–10.34) independently and significantly emerged as risk factors for CAD.
Conclusions
Hypertension, diabetes mellitus, former smoking, physical inactivity, and less fruit and vegetable intake were independent and significant modifiable risk factors for CAD in the Indonesian population.
Special Article
Barriers in Salt Reduction Strategies: Time to Acting for the Future
Yong-Jae Kim
Cardiovasc Prev Pharmacother. 2020;2(4):134-141.   Published online October 31, 2020
DOI: https://doi.org/10.36011/cpp.2020.2.e16
  • 2,280 View
  • 36 Download
Abstract PDF
Salt reduction is important for reducing hypertension and the risk of cardiovascular events and stroke. Despite knowledge about the ill consequences, many people continue to consume high levels of salt in their diet. This paper introduces salt-reducing programs for individual, population, and country-level strategies to reduce salt intake. To effectively decrease salt intake, it is necessary to reduce the consumption of high-salt foods and replace high-salt seasonings with low-salt alternatives. Thus, healthcare professionals must effectively provide information on salt-reduction for patients with hypertension. Social strategies, such as voluntary sodium reduction targets for the food industry, are necessary to promote population strategies for salt reduction. In this paper, we examine a brief report on new salt intake values based on chronic disease risk reduction and explain the utilization of mobile health technologies to reduce salt consumption. Considering the relationship between dietary salt intake and the risk of chronic disease, ways to remove the barriers to strategies for salt reduction should be considered, as it is the most effective way for the prevention and control of hypertension and cardiovascular disease in the future.
Review Article
Prevention of Type 2 Diabetes
Jong Dai Kim, Won-Young Lee
Cardiovasc Prev Pharmacother. 2020;2(3):63-76.   Published online July 31, 2020
DOI: https://doi.org/10.36011/cpp.2020.2.e10
  • 2,440 View
  • 34 Download
Abstract PDF
The number of patients with type 2 diabetes (T2D) is increasing worldwide and that in Korea, particularly, has shown an exponential increase with a rise in the older population. The diabetic population is predicted to soar up to 6 million by 2050. The prevalence of diabetes among Korean adults is approximately 15%, while that of prediabetes is 25%, with a total prevalence of 40%. As 40% of the prediabetes cases subsequently progress to T2D, prevention through proactive interventions at the prediabetes stage is essential to reduce the socioeconomic burden due to T2D and the complications of diabetes. With regard to the prevention of T2D, new findings have been published related to the implementation of lifestyle interventions such as exercise and diet as well as drug treatments and surgeries, which have deepened our understanding of the prevention of T2D. Based on published evidence, this review aimed to examine the methods used in the prevention of diabetes.
Special Article
Effects of Low-Carbohydrate, High-Fat Diets on Weight Loss, Cardiovascular Health and Mortality
Bo-Yeon Kim
Cardiovasc Prev Pharmacother. 2020;2(2):43-49.   Published online April 30, 2020
DOI: https://doi.org/10.36011/cpp.2020.2.e7
  • 4,210 View
  • 46 Download
  • 1 Citations
Abstract PDF
Obesity is a worldwide health challenge. The clinical consequences of obesity include nonalcoholic fatty liver disease, type 2 diabetes, and coronary heart disease. Numerous diets have been developed to reduce the incidence of cardiovascular diseases and induce weight loss. Low-carbohydrate, high-fat diets (LCHFDs) have become increasingly popular for weight loss. LCHFDs have led to weight loss in some clinical studies. However, the safety of LCHFDs and their long-term effects on the human body are still controversial. In this review, I will discuss the effects of LCHFDs on weight loss, cardiovascular health, and mortality.

Citations

Citations to this article as recorded by  
  • Cholesterol, fatty acids profile and the indices of atherogenicity and thrombogenicity of raw lamb and mutton offal
    B. Pretorius, H.C. Schönfeldt
    Food Chemistry.2021; 345: 128868.     CrossRef

CPP : Cardiovascular Prevention and Pharmacotherapy